Publication | Open Access

Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer

Surgical OncologyRadiation TherapyMedicineNeoadjuvant BevacizumabSurgeryShort-course RadiotherapyClinical Radiation OncologyOncologyRadiation Oncology